What does CUSIP 18978H201 represent in this 13F holders report?

CUSIP 18978H201 is the security identifier for CNSP - CNS PHARMACEUTICALS INC - COM NEW used to aggregate holder disclosures.

How many institutions held CNSP - CNS PHARMACEUTICALS INC - COM NEW in Q3 2023?

12 institutional investors reported CNSP - CNS PHARMACEUTICALS INC - COM NEW for Q3 2023. Use the holders table for investor-level position and value details.

CNS PHARMACEUTICALS INC - COM NEW (CNSP)

CUSIP: 18978H201

Q3 2023 13F Holders as of 30 Sep 2023

Security type / class: Equity / COM NEW
Total 13F shares: 116,697
Total 13F value: $131,663
Share change: +11,902
SEC-reported price per share: $1.14
Number of holders: 12
Value change: -$10,667
Number of buys: 6
Number of sells: 3

Security key

18978H201

Report period

Q3 2023

Institutions

Top holders

CNSP full security history Ownership snapshot Full 13F holder table CNS Pharmaceuticals, Inc. SEC filings CNS Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CNSP - CNS PHARMACEUTICALS INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Waldemar Priebe

Disclosed value leader

Waldemar Priebe

Comparable rows

0/14

Latest evidence

21 Sep 2023

3/4/5 13F Highest disclosed value: $198,486 14 rows are not safely comparable across share classes. Showing 1-6 of 14 holder rows.

Quick read

Waldemar Priebe has the largest disclosed position value at $198.5K.

0 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Waldemar Priebe's linked filing trail.

Disclosed position value Top 5

Waldemar Priebe $198.5K

VANGUARD GROUP INC $53K

STATE STREET CORP $50.3K

ACADIAN ASSET MANAGEMENT LLC $49K

FSM Wealth Advisors, LLC $37.9K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 14 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Waldemar Priebe	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$198,486 156,807 shares	—	06 Dec 2022
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$52,996 23,765 shares	—	30 Jun 2023
STATE STREET CORP	13F Company 13F	— denominator unverified	$50,300 22,556 shares	—	30 Jun 2023
ACADIAN ASSET MANAGEMENT LLC	13F Company 13F	— denominator unverified	$49,000 22,292 shares	—	30 Jun 2023
FSM Wealth Advisors, LLC	13F Company 13F	— denominator unverified	$37,895 16,334 shares	—	30 Jun 2023
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$35,996 16,142 shares	—	30 Jun 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

116,697

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

Q3 2023 holders

Holder diff

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 value	Q3 2023 value	Value change	Value Chg %